血液恶性肿瘤男童睾丸功能的前瞻性纵向评估
该前瞻性纵向队列研究纳入63名阿根廷三级儿科中心2013–2019年治疗的急性淋巴细胞白血病、急性髓系白血病或非霍奇金淋巴瘤男童及青少年,从诊断、化疗期间至治疗结束后3年连续评估支持细胞和间质细胞功能。结果显示睾丸功能障碍大多可逆,但支持细胞成熟延迟和持续性代偿性间质细胞功能不全是残留睾丸脆弱性的表现,强调长期内分泌监测的重要性。
要点
- 儿童血液恶性肿瘤相关睾丸功能障碍大多可逆。
- 青春期前支持细胞功能轻度受损,AMH在诱导化疗期间升高后恢复正常。
- 青春期患者出现短暂生精小管功能障碍,治疗结束后3年恢复。
核心结论
- 儿童血液恶性肿瘤相关睾丸功能障碍大多可逆,但支持细胞成熟延迟和持续性代偿性间质细胞功能不全是残留睾丸脆弱性的表现。
研究设计与样本
- 前瞻性纵向队列研究,纳入63名在阿根廷三级儿科中心2013–2019年治疗的急性淋巴细胞白血病、急性髓系白血病或非霍奇金淋巴瘤男童及青少年。
- 从诊断、整个化疗期间至治疗结束后3年连续评估支持细胞标志物(AMH、抑制素B、FSH)和间质细胞功能标志物(睾酮、LH)。
主要发现
- 青春期前男童诊断时支持细胞功能轻度受损,AMH和FSH水平降低。
- AMH在诱导化疗期间升高,治疗期间波动,之后恢复正常并稳定至治疗结束后3年。
- 短暂FSH抑制与暴露于高剂量皮质类固醇同时发生。
- 随访期间进入青春期的男童AMH相对于青春期分期持续升高,提示支持细胞成熟延迟。
- 青春期患者出现短暂生精小管功能障碍,表现为FSH升高和抑制素B降低,治疗结束后3年恢复。
临床怎么用
- 对儿童血液恶性肿瘤男童及青少年应在化疗期间及治疗结束后进行长期内分泌监测。
- 关注支持细胞成熟延迟和代偿性间质细胞功能不全的迹象。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Survival after pediatric hematologic malignancies has improved substantially, increasing concern regarding endocrine sequelae. While gonadotoxic effects on germ cells are characterized in adult survivors, the early impact of cancer and chemotherapy on hypothalamic-pituitary-testicular axis during childhood and adolescence remains insufficiently studied. DESIGN: We conducted a prospective longitudinal cohort study including 63 boys and adolescents with acute lymphoblastic leukemia, acute myeloid leukemia, or non-Hodgkin lymphoma treated at a tertiary pediatric center in Argentina between 2013 and 2019. Hormonal markers of Sertoli cell (AMH, inhibin B, FSH) and Leydig cell function (testosterone, LH) were serially assessed from diagnosis, throughout chemotherapy, and up to 3 years after treatment completion. RESULTS: In prepubertal boys, Sertoli cell function was mildly impaired at diagnosis, with reduced AMH and FSH levels. AMH increased during induction chemotherapy, fluctuated during treatment, and normalized thereafter, remaining stable up to 3 years post-treatment. Transient FSH suppression coincided with exposure to high-dose corticosteroids. Boys entering puberty during follow-up showed persistently elevated AMH relative to pubertal stage, suggesting delayed Sertoli cell maturation. In pubertal patients, a transient seminiferous tubular dysfunction, reflected by increased FSH and decreased inhibin B occurred, with recovery by 3 years after treatment. Mild compensated Leydig cell dysfunction persisted, characterized by elevated LH despite normal testosterone concentrations. CONCLUSIONS: Testicular dysfunction associated with pediatric hematologic malignancies is mostly reversible. However, delayed Sertoli cell maturation and persistent compensated Leydig cell insufficiency indicate residual testicular vulnerability, underscoring the importance of long-term endocrine surveillance during and after the end of chemotherapy.
引用
- Lopez Dacal J, Prada S, Soria M, et al. Assessment of testicular function in boys with hematological malignancies: a prospective longitudinal study. J Clin Endocrinol Metab. 2026. PMID: 42689341. doi:10.1210/clinem/dgag365
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。